Phreesia, Inc. (NYSE:PHR) Shares Sold by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. trimmed its holdings in Phreesia, Inc. (NYSE:PHR) by 22.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 100,656 shares of the company’s stock after selling 28,793 shares during the period. Mirae Asset Global Investments Co. Ltd. owned 0.18% of Phreesia worth $2,330,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of PHR. International Assets Investment Management LLC increased its position in Phreesia by 1,987.3% during the fourth quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock worth $34,000 after purchasing an additional 1,411 shares during the last quarter. Captrust Financial Advisors increased its position in Phreesia by 154.6% during the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock worth $36,000 after purchasing an additional 866 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in Phreesia during the first quarter worth about $43,000. State of Wyoming boosted its stake in Phreesia by 34.6% during the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock worth $59,000 after buying an additional 493 shares during the period. Finally, Tower Research Capital LLC TRC boosted its stake in Phreesia by 85.4% during the third quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock worth $80,000 after buying an additional 1,445 shares during the period. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Stock Down 2.3 %

Shares of NYSE:PHR opened at $22.62 on Friday. The firm’s 50 day moving average price is $24.40 and its 200 day moving average price is $21.26. The stock has a market cap of $1.28 billion, a price-to-earnings ratio of -8.98 and a beta of 0.92. Phreesia, Inc. has a fifty-two week low of $12.05 and a fifty-two week high of $34.98. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHR) last issued its earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share for the quarter, beating the consensus estimate of ($0.58) by $0.02. The firm had revenue of $95.00 million for the quarter, compared to analysts’ expectations of $93.52 million. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The firm’s revenue was up 24.0% compared to the same quarter last year. During the same quarter last year, the company earned ($0.72) earnings per share. As a group, equities research analysts predict that Phreesia, Inc. will post -1.48 earnings per share for the current fiscal year.

Insider Activity at Phreesia

In related news, COO Evan Roberts sold 25,962 shares of the firm’s stock in a transaction that occurred on Thursday, March 21st. The shares were sold at an average price of $23.52, for a total value of $610,626.24. Following the sale, the chief operating officer now owns 728,570 shares of the company’s stock, valued at $17,135,966.40. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Phreesia news, CEO Chaim Indig sold 12,043 shares of the firm’s stock in a transaction that occurred on Monday, April 8th. The shares were sold at an average price of $22.62, for a total transaction of $272,412.66. Following the sale, the chief executive officer now owns 1,225,397 shares of the company’s stock, valued at $27,718,480.14. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Evan Roberts sold 25,962 shares of the firm’s stock in a transaction that occurred on Thursday, March 21st. The stock was sold at an average price of $23.52, for a total transaction of $610,626.24. Following the sale, the chief operating officer now directly owns 728,570 shares in the company, valued at approximately $17,135,966.40. The disclosure for this sale can be found here. Insiders have sold a total of 81,808 shares of company stock valued at $1,884,749 over the last 90 days. 5.80% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have weighed in on PHR. DA Davidson reaffirmed a “neutral” rating and set a $32.00 target price on shares of Phreesia in a research note on Friday, March 15th. Raymond James reaffirmed an “outperform” rating and set a $30.00 target price (up previously from $25.00) on shares of Phreesia in a research note on Friday, March 15th. Barclays began coverage on shares of Phreesia in a research note on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 target price for the company. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 target price on shares of Phreesia in a research note on Friday, March 15th. Finally, Truist Financial began coverage on shares of Phreesia in a research note on Monday, February 26th. They set a “buy” rating and a $35.00 target price for the company. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $31.62.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.